Personal Importation

FDA’s Drug Competition Action Plan (DCAP) encourages robust and timely market competition for generic drugs and helps bring greater efficiency and transparency to the generic drug review process, without sacrificing the scientific rigor underlying our generic drug program.

Stories illustrating how regulatory science impacts the lives and health of people

CGMP/OTC/Unapproved New Drugs/Misbranded

Find answers to the most asked questions about medication health fraud and how to identify scams when buying products.

Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 03/27/2025
Short Title (70 char) BlendHouse Portland LLC. Portland, OR. EIR issued 03/27/2025
FEI Number 3013670080
Firm Name BlendHouse Portland LLC
Record Type EIR
State OR
Establishment Type Manufacturer

Rogue online pharmacies offer potentially dangerous prescription drugs to U.S. consumers. FDA has issued warning letters informing the website operators that they are engaged in illegal activity in violation of the U.S. Federal Food, Drug, and Cosmetic Act